Interpace Biosciences, Inc. (IDXG)
1.523
-0.09
(-5.42%)
USD |
OTCM |
Aug 21, 16:00
Interpace Biosciences Total Assets (Quarterly) : 34.55M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.55M |
| March 31, 2026 | 33.41M |
| December 31, 2025 | 33.84M |
| September 30, 2025 | 12.04M |
| June 30, 2025 | 12.34M |
| March 31, 2025 | 14.49M |
| December 31, 2024 | 14.79M |
| September 30, 2024 | 14.04M |
| June 30, 2024 | 12.97M |
| March 31, 2024 | 12.14M |
| December 31, 2023 | 13.12M |
| September 30, 2023 | 14.25M |
| June 30, 2023 | 15.94M |
| March 31, 2023 | 15.88M |
| December 31, 2022 | 15.98M |
| September 30, 2022 | 15.29M |
| June 30, 2022 | 35.49M |
| March 31, 2022 | 38.36M |
| December 31, 2021 | 38.43M |
| September 30, 2021 | 40.31M |
| June 30, 2021 | 43.18M |
| March 31, 2021 | 43.86M |
| December 31, 2020 | 45.68M |
| September 30, 2020 | 50.70M |
| June 30, 2020 | 60.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 60.78M |
| December 31, 2019 | 51.54M |
| September 30, 2019 | 74.67M |
| June 30, 2019 | 50.33M |
| March 31, 2019 | 54.38M |
| December 31, 2018 | 48.44M |
| September 30, 2018 | 49.80M |
| June 30, 2018 | 51.36M |
| March 31, 2018 | 53.10M |
| December 31, 2017 | 53.60M |
| September 30, 2017 | 50.39M |
| June 30, 2017 | 53.74M |
| March 31, 2017 | 46.98M |
| December 31, 2016 | 41.78M |
| September 30, 2016 | 45.96M |
| June 30, 2016 | 53.51M |
| March 31, 2016 | 56.78M |
| December 31, 2015 | |
| September 30, 2015 | 99.29M |
| June 30, 2015 | 107.57M |
| March 31, 2015 | 112.61M |
| December 31, 2014 | 115.91M |
| September 30, 2014 | 62.23M |
| June 30, 2014 | 59.46M |
| March 31, 2014 | 65.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.4457M |
| Xcelerate, Inc. | 0.2193M |
| Vivos Therapeutics, Inc. | 24.14M |
| Hinge Health, Inc. | 827.40M |
| PD-Rx Pharmaceuticals, Inc. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.30M |
| Shareholders Equity (Quarterly) | 23.24M |
| Debt to Equity Ratio | 0.0419 |
| Current Ratio | 2.215 |
| Net Debt Paydown Yield | 1.45% |